111 related articles for article (PubMed ID: 37712121)
1. Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma.
Wang Q; Wang Z
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23541. PubMed ID: 37712121
[TBL] [Abstract][Full Text] [Related]
2. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
3. [Bioinformatic analysis of immune correlation and prognostic value of SERPINs in glioma].
Jia Y; Wang G; He X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Feb; 38(2):122-130. PubMed ID: 35356880
[TBL] [Abstract][Full Text] [Related]
4. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis.
Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y
J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582
[TBL] [Abstract][Full Text] [Related]
5. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
6. ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma.
Zhang D; Wang W; Zhou H; Su L; Han X; Zhang X; Han W; Wang Y; Xue X
Front Genet; 2022; 13():851505. PubMed ID: 35711921
[No Abstract] [Full Text] [Related]
7. A Four-Gene Panel for the Prediction of Prognosis and Immune Cell Enrichment in Gliomas.
Li Z; Jin Y; Zhang P; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Qiu X; Chen C; Que T; Huang G
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37644261
[TBL] [Abstract][Full Text] [Related]
8. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
9. High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma.
Zhang H; Yan X; Gu H; Xue Q; Liu X
J Thorac Dis; 2022 Dec; 14(12):4785-4802. PubMed ID: 36647484
[TBL] [Abstract][Full Text] [Related]
10. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
11. Network Analyses of the Differential Expression of Heat Shock Proteins in Glioma.
Sun H; Zou HY; Cai XY; Zhou HF; Li XQ; Xie WJ; Xie WM; Du ZP; Xu LY; Li EM; Wu BL
DNA Cell Biol; 2020 Jul; 39(7):1228-1242. PubMed ID: 32429692
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas.
Lu J; Liang K; Zou R; Peng Y; Wang H; Huang R; Zeng Z; Feng Z; Fan Y; Zhang S; Ji Y; Pang X; Wang Y; Zhang H; Wang Z
Aging (Albany NY); 2023 Jun; 15(12):5798-5825. PubMed ID: 37367937
[TBL] [Abstract][Full Text] [Related]
13. SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis.
Wang Y; Gu W; Wen W; Zhang X
Front Genet; 2021; 12():756094. PubMed ID: 35058967
[No Abstract] [Full Text] [Related]
14. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
15. FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.
Sun Z; Sun X; Yuan Y; Li H; Li X; Yao Z
Medicine (Baltimore); 2023 Sep; 102(37):e35084. PubMed ID: 37713871
[TBL] [Abstract][Full Text] [Related]
16. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
17. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Liu J; Li G
Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of bulk RNA-seq and scRNA-seq data indicates the prognostic and immunologic values of SERPINH1 in glioma.
Hou S; Chen Y; Jin C; Lin N
Environ Toxicol; 2024 Jun; 39(6):3654-3665. PubMed ID: 38506564
[TBL] [Abstract][Full Text] [Related]
20. Collagen family genes and related genes might be associated with prognosis of patients with gastric cancer: an integrated bioinformatics analysis and experimental validation.
Weng K; Huang Y; Deng H; Wang R; Luo S; Wu H; Chen J; Long M; Hao W
Transl Cancer Res; 2020 Oct; 9(10):6246-6262. PubMed ID: 35117235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
